• Home
  • Market
  • Nomura Boosts Outlook on Chinese Stocks Following US-China Trade Truce Over Trump’s Tariffs
Nomura Boosts Outlook on Chinese Stocks Following US-China Trade Truce Over Trump's Tariffs

Nomura Boosts Outlook on Chinese Stocks Following US-China Trade Truce Over Trump’s Tariffs

Recent developments in the trade relationship between the U.S. and China have led Nomura Holdings Inc. to shift its outlook on Chinese stocks, upgrading them to a “tactical overweight.” This strategic move signals optimism among investors, as the easing of trade tensions is expected to bolster China’s equity market significantly. The analysts, led by Chetan Seth, noted that the latest trade agreements could help diminish the geopolitical risk premium that has long haunted Chinese stocks.

Positive Trade Developments Boost Market Sentiment

The change in Nomura’s assessment comes in light of encouraging discussions over the weekend that yielded better-than-anticipated outcomes. As part of the agreement, the U.S. government plans to cut tariffs on a majority of Chinese imports to 30% for 90 days, while China will reduce its tariffs on U.S. goods to 10%. President Donald Trump also indicated that China has committed to eliminating certain non-tariff barriers, further improving the trade landscape.

  • U.S. Tariffs: Reduced to 30% for 90 days
  • China Tariffs: Dropped to 10%
  • Trump’s Statement: China to remove non-tariff barriers

Market Reactions and Future Projections

The agreement has lifted some weight off the market, leading analysts to express growing optimism about increased inflows into Chinese shares. Leading up to the negotiations, local markets had already shown a positive trend, boosted by a recent interest rate cut and assurances from policymakers to support the “stock stabilization fund.”

However, the Chinese onshore benchmark index experienced a slight dip, paring its gains of up to 0.6%, as the reduction in tariffs tempered expectations for extensive stimulus measures from China. Similarly, a gauge of Chinese shares listed in Hong Kong saw a decline of 1.8% on Tuesday.

See also  Top 7 Dividend Stocks to Watch: Dr. Reddy's, Navin Fluorine, and Birla Corporation Lead the Pack!

Currency Gains Amidst Trade Optimism

In more encouraging news, the yuan soared to a six-month high in both onshore and offshore markets on Tuesday, following the People’s Bank of China setting a stronger currency fixing above the 7.2 per dollar mark. This shows increased confidence in the Chinese economy as trade tensions ease.

Shifting Focus: India vs. China Investments

In a strategic pivot, Nomura has downgraded its overweight stance on Indian stocks to fund its upgrade of Chinese equities. This reflects the first significant upgrade of China’s allocation by analysts since the two economic giants agreed to a temporary pause in their trade conflict.

The strategists pointed out that maintaining overweight positions in both India and China offers investors a natural hedge against potential trade-related volatility. They emphasized that while the market had anticipated some tariff reductions, the actual outcomes exceeded expectations, providing substantial relief for global stocks.

  • Nomura’s Strategy: Downgraded India to support China allocation
  • Investor Hedge: Balancing positions in India and China

This optimistic landscape sets the stage for potential growth in Asian equity markets, as investors recalibrate their strategies in response to the evolving trade dynamics between the U.S. and China.

Related Post

US crude imports hit 4-year low on weak refinery demand
US Dollar Dips Following Unexpectedly Low Consumer Price Index Results
ByAbhinandanMay 14, 2025

The U.S. dollar declined on Tuesday after a Labor Department report indicated a 0.2% rise…

ITD Cementation Soars: Q4 Profit Surges 27% and Margin Growth Shines
ITD Cementation Soars: Q4 Profit Surges 27% and Margin Growth Shines
ByAbhinandanMay 13, 2025

ITD Cementation India Ltd. reported strong financial growth in Q4 FY25, with a 27% increase…

GlaxoSmithKline Reports Impressive Q4 Earnings: 36% Profit Surge to ₹263 Crore!
GlaxoSmithKline Reports Impressive Q4 Earnings: 36% Profit Surge to ₹263 Crore!
ByAbhinandanMay 13, 2025

GlaxoSmithKline Pharmaceuticals Ltd. reported strong financial growth for fiscal year 2025, with a consolidated net…

FPIs Shift Gears: Net Selling Trends Unveiled After Just One Day
FPIs Shift Gears: Net Selling Trends Unveiled After Just One Day
ByAbhinandanMay 13, 2025

On Tuesday, foreign investors turned net sellers of Indian equities, offloading shares worth ₹476.86 crore,…

Leave a Reply

Your email address will not be published. Required fields are marked *

JOIN US

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!